Publication | Open Access

Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial

RheumatologyOral FingolimodOphthalmologyChronic InflammatoryForcidp TrialMedicineSymptomatic TreatmentClinical TrialsNeuropathic PainNeurologyMultiple SclerosisNeuropathologyNeuroimmunology